JPRN-UMIN000032665招募中未知
The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy. - The efficacy and the utility of switching from basal-bolus therapy to GLP-1 RA plus basal insulin therapy.
Department of Endocrinology, Nippon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 100 人开始时间: 2018年5月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 diabetes with severe liver disease, severe renal disease or severe heart disease with any carcinoma under pregnancy
研究者
相似试验
已完成
不适用
The evaluation of the efficacy of a switch from GnRH agonist to GnRH antagonist in prostate cancer patients who relapsed during combined androgen blockade.prostate cancerJPRN-UMIN000013514Tokai Urological Clinical Trial Group50
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120
招募中
不适用
The efficacy and safety of switching from linagliptin to once-weekly dulaglutide in hemodialysis patients with type 2 diabetes mellitus (pilot study)Type 2 diabetes mellitusJPRN-UMIN000021944Minamisenju Hospital20
尚未招募
3 期
B/F/TAF to DTG/3TC Switch StudyHIV/AIDSPACTR202404870570433niversity of Nairobi240
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30